Using nanomaterials to understand and influence immune responses
Polymeric Nanomaterials for Probing and Modulating Innate Immune Responses
This study is looking at how tiny materials made from polymers can affect immune cells and their role in inflammation, with the goal of helping people with chronic inflammatory diseases by finding ways to improve immune responses without causing harm.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Massachusetts Amherst NIH-funded |
| Lab location | 1 site (Hadley, United States) |
| Project ID | NIH-11075766 on NIH RePORTER |
What this research studies
This research investigates how polymeric nanomaterials interact with immune cells to either provoke or modulate inflammatory responses. By focusing on the inflammasome, a protein complex involved in inflammation, the study aims to develop better tools for understanding chronic inflammatory diseases. Patients may benefit from insights into how these nanomaterials can be designed to improve immune responses without causing harmful inflammation. The research employs advanced immunoengineering techniques to explore these interactions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from chronic inflammatory diseases who may benefit from improved immune modulation.
Not a fit: Patients with acute inflammatory conditions or those not affected by chronic inflammation may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that effectively manage chronic inflammatory diseases by fine-tuning immune responses.
How similar studies have performed: Previous studies have shown promise in using nanomaterials to target immune cells, but this specific approach to modulating inflammasome activation is relatively novel.
Where this research is happening
Hadley, United States
- University of Massachusetts Amherst — Hadley, United States (Active)
Researchers
- Principal investigator: Kulkarni, Ashish a. — University of Massachusetts Amherst
- Study coordinator: Kulkarni, Ashish a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.